You have read all your free articles, to continue reading subscribe to read the rest of this content.
Gedea Biotech has received its certificate in accordance with ISO 13485: 2016 (Medical devices - Quality management system - Requirements for regulatory purposes). The scope of the certificate includes design, development, marketing, distribution and production of antibiotic-free vaginal tablets Already a subscriber Login You have read all your free articles,…
An online petition opposing AstraZeneca PLC’s plans to build an animal testing lab as part of a proposed research center has collected almost 5,000 signatures in fewer than two weeks. The animal rights activist organization Cambridge against AstraZeneca PLC Planning, or CAP, is opposed to the pAlready a subscriber Login…
The company has appointed Scott Coiante as Senior Vice President and Chief Financial Officer. An experienced finance executive in biotech, Mr. Coiante brings nearly 20 years of accounting, fundraising and operational experience to Aprea. “Aprea is leading the way in developing small moleculeAlready a subscriber Login You have read all…
Xbrane Biopharma and its co-development partner STADA have entered into an exclusive licensing agreement with Bausch + Lomb to commercialize Xlucane, a Lucentis (ranibizumab) biosimilar candidate, in the United States and Canada. The companies aim to obtain regulatory approval of all currently apAlready a subscriber Login You have read all…
